<scp>LC</scp> ‐ <scp>OCT</scp> for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology
LC-OCT appears to be a promising tool for the early differential diagnosis of adverse skin reactions related to targeted therapy and immunotherapy, offering the potential to avoid skin biopsies in fragile cancer patients.
Authors
- Simone Cappilli (ORCID: https://orcid.org/0000-0001-9813-2391)
- Alessandro Di Stefani (ORCID: https://orcid.org/0000-0001-8283-2633)
- Gerardo Palmisano (ORCID: https://orcid.org/0009-0000-9681-1681)
- Lucia Di Nardo (ORCID: https://orcid.org/0000-0002-2087-7526)
- Luca Pellegrino (ORCID: https://orcid.org/0000-0002-2475-3475)
- Pietro Sollena (ORCID: https://orcid.org/0000-0002-1632-7791)
- Maria Mannino (ORCID: https://orcid.org/0000-0001-7246-7951)
- Ketty Peris (ORCID: https://orcid.org/0000-0003-1957-6600)
- Marisa Salvi
- Marica Marraffa
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2024-11-03
- DOI
- https://doi.org/10.1111/ijd.17520
- Citations
- 1
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.53